M&A: Opus Genetics, Inc.

Form Type: 8-K/A

Filing Date: 2025-01-07

Corporate Action: Acquisition

Type: Update

Accession Number: 000114036125000467

Comments: On October 22, 2024, Opus Genetics, Inc. completed its acquisition of former Opus Genetics Inc., a Delaware corporation, as reported in the Original Form 8-K. This acquisition was governed by the Agreement and Plan of Merger dated October 22, 2024. The Company sought relief from the SEC from filing historical audited financial statements for the Acquired Company, believing they would not be material to stockholders. The SEC permitted the Company to file only the audited financial statements for the fiscal year ended December 31, 2023, and unaudited interim financial statements for the nine months ended September 30, 2024. Pro forma financial information presenting the combined results of operations is included for informational purposes and does not guarantee future performance. The filing also includes various exhibits containing financial statements and the consent of the independent accounting firm.

Document Link: View Document